Month: October 2022

Keto Maple Pumpkin Scones – Diabetes Daily Learning Center Learning Center: LearningCenter Diabetes Daily does not provide medical advice,diagnosis or treatment.Get additional information.© 2005 – 2022 Everyday Health, Inc. Everyday Health is among the federally registered trademarks of Everyday Health, Inc. and may not be used by third parties without explicit permission.
0 Comments
Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, August 29, 2020. Andrew Kelly | Reuters The Food and Drug Administration on Friday approved a vaccine for use in the third trimester of pregnancy to prevent whooping cough in newborn infants. The vaccine, called Boostrix, is made by
0 Comments
Acting swiftly and decisively to extinguish the Ebola outbreak in Uganda is an important priority not just for Uganda, but for Africa and the world. The current outbreak has, thus far, been confirmed to have killed 10 — including 4 healthcare workers — and while over 40 cases have been confirmed, none have been outside
0 Comments
A team led by a West Virginia University biomedical engineer is working to ramp up and reimagine how medical professionals diagnose tick-borne infections such as Lyme disease. Soumya Srivastava, assistant professor at the Benjamin M. Statler College of Engineering and Mineral Resources, is developing a tool that more quickly detects tick-borne diseases via a blood
0 Comments
For Many in Poorer Nations, Type 1 Diabetes is Still a Death Sentence – Diabetes Daily Learning Center Learning Center: LearningCenter Diabetes Daily does not provide medical advice,diagnosis or treatment.Get additional information.© 2005 – 2022 Everyday Health, Inc. Everyday Health is among the federally registered trademarks of Everyday Health, Inc. and may not be used
0 Comments
A patient receives a Covid-19 vaccine booster shot at a Pfizer-BioNTech vaccination clinic in Southfield, Michigan, on Sept. 29, 2021. Emily Elconin | Reuters Covid vaccines prevented at least 330,000 deaths and nearly 700,000 hospitalizations among adult Medicare recipients in 2021, the Health and Human Services Department said in a new report published Friday. The
0 Comments
A simple screening tool based on cough, wheeze, and medication use flagged asthma risk in 3-year-olds with greater accuracy than standard strategies, researchers reported. The CHILDhood Asthma Risk Tool (CHART) outperformed specialists’ assessments and the modified Asthma Predictive Index (mAPI) for predicting asthma diagnosis by age 5 in one cohort and was validated for prediction
0 Comments
Financial incentives to encourage home dialysis may be falling flat, according to a first-year analysis of Medicare’s End-Stage Renal Disease (ESRD) Treatment Choices (ETC) Model. Compared with controls, ESRD facilities and managing clinicians practicing within a hospital referral region randomized to receive financial incentives only increased the number of new patients with home dialysis in
0 Comments
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The COVID-19 pandemic fueled a sharp uptick in deaths related to chronic liver disease and cirrhosis among people with diabetes, largely owing to nonalcoholic fatty liver disease (NAFLD) and alcohol-related liver disease (ALD), new data show. “Our observations confirm that COVID-19
0 Comments
Occasional bouts of heartburn are nothing to worry about. But if you get it frequently you’re at a higher risk of developing Barrett’s esophagus which in rare cases can lead to esophageal cancer. Doctors at Mayo Clinic have studied a new treatment for Barrett’s that may significantly reduce your chances of developing esophageal cancer.
0 Comments
CNN  —  The pandemic has been tough, but the return to in-person schooling has also been emotionally difficult for Mary Norris’ 12-year-old daughter. Norris says her daughter was bullied relentlessly at the school she attended last year in Fresno, California, near where her father lives. So she transferred to a school in Madera, where her
0 Comments
The angiotensin II receptor blocker (ARB) telmisartan (Micardis) did not significantly improve walking performance in patients with lower-extremity peripheral artery disease (PAD) in a randomized controlled trial. From baseline to 6 months, the average change in the primary outcome of 6-minute walk test distance was 1.32 m for telmisartan and 12.5 m for placebo. The
0 Comments
Findings from a small study of eight patients published in Clinical Infectious Diseases suggest that COVID-19 rebound is likely not caused by impaired immune responses. The study, led by scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, aimed to define the clinical course and the
0 Comments